Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Njouom, Richard ^a   Mba, Serge A S ^a   Noah, Dominique N ^b   Gregory, Victoria ^c   Collins, Patrick ^c   Cappy, Pierre ^a   Hay, Alan ^c   Rousset, Dominique ^a  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b Ministry of Health   (Cameroon)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLYCINE; OSELTAMIVIR; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CAMEROON; CENTRAL AFRICA; ENZYME ASSAY; ENZYME INHIBITION; FEMALE; HUMAN; IC 50; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS VIRULENCE; ADOLESCENT; AGED; ANIMAL; CELL LINE; CHILD; CLASSIFICATION; DOG; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEMAGGLUTINATION INHIBITION TEST; INFANT; INFLUENZA; ISOLATION AND PURIFICATION; MIDDLE AGED; NOSE; ORTHOMYXOVIRUS; PHARYNX; PRESCHOOL CHILD; PREVALENCE; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CAMEROON; CELL LINE; CHILD; CHILD, PRESCHOOL; DOGS; DRUG RESISTANCE, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NOSE; ORTHOMYXOVIRIDAE; OSELTAMIVIR; PHARYNX; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; YOUNG ADULT;

EID: 77950431786     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-56     Document Type: Article

References (16)

1. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996, 18(1):64-76.
2. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002, 20(25-26):3068-3087. 10.1016/S0264-410X(02)00254-2, 12163258.
3. WHO Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Wkly Epidemiol Rec 2008, 83(9):81-87. WHO.
4. WHO Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec 2008, 83(41):366-372. WHO.
5. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351(9101):472-477. 10.1016/S0140-6736(97)11212-0, 9482438.
6. Stohr K. The global agenda on influenza surveillance and control. Vaccine 2003, 21(16):1744-1748. 10.1016/S0264-410X(03)00065-3, 12686087.
7. Akoua-Koffi C, Kouakou B, Kadjo H, Elia G, Koffi SP, Adjogoua E, Dosso M, Ehouman A. [Results of two-year surveillance of flu in Abidjan, Cote d'Ivoire]. Med Trop (Mars) 2007, 67(3):259-262.
8. Besselaar TG, Botha L, McAnerney JM, Schoub BD. Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. J Med Virol 2004, 73(1):71-78. 10.1002/jmv.20063, 15042651.
9. Dosseh A, Ndiaye K, Spiegel A, Sagna M, Mathiot C. Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998. Am J Trop Med Hyg 2000, 62(5):639-643.
10. Gachara G, Ngeranwa J, Magana JM, Simwa JM, Wango PW, Lifumo SM, Ochieng WO. Influenza virus strains in Nairobi, Kenya. J Clin Virol 2006, 35(1):117-118. 10.1016/j.jcv.2005.10.004, 16309952.
11. Rabarijaona LP, Rakotondrarija NT, Rousset D, Soares JL, Mauclere P. [Influenza epidemiologic and virologic surveillance in Antananarivo from 1995 to 2002]. Arch Inst Pasteur Madagascar 2003, 69(1-2):20-26.
12. Spackman E, Senne D, Myers TJ, Bulaga L, Garber L, Perdue M, Lohman K, Daum L, Suarez D. Development of a Real-Time Reverse Transcriptase PCR Assay for Type A Influenza Virus and the Avian H5 and H7 Hemagglutinin Subtypes. J Clin Microbiol 2002, 40:3256-3260. 10.1128/JCM.40.9.3256-3260.2002, 130722, 12202562.
13. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem 1979, 94:287-296. 10.1016/0003-2697(79)90362-2, 464297.
14. Wetherall N, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin J, Zambon M, Hayden F. Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network. J Clin Microbiol 2003, 41:742-750. 10.1128/JCM.41.2.742-750.2003, 149673, 12574276.
15. Meijer A, Lackenby A, Hungnes O, Lina B, Werf S, Schweiger B, Opp M, Paget J, Kassteele J, Hay A, Zambon M. Oseltamivir-resistant influenza virus A(H1N1), Europe, 2007-08 season. Emerg Infect Dis 2009, 15(4):552-560. 10.3201/eid1504.081280, 2671453, 19331731.
16. Besselaar TG, Naidoo D, Buys A, Gregory V, McAnerney JM, Manamela JM, Blumberg L, Schoub BD. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis 2008, 14(11):1809-1810. 10.3201/eid1411.080958, 2630761, 18976580.